APVO
Aptevo Therapeutics Inc · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website aptevotherapeutics.com
- Employees(FY) 45
- ISIN US03835L3069
Performance
-14.44%
1W
+4.17%
1M
-88.11%
3M
-90.01%
6M
-89.95%
YTD
-98.92%
1Y
Profile
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company's lead clinical candidates are APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndromes; and. ALG.APV-527, an investigational bispecific ADAPTIR candidate that features a mechanism of action to target 4-1BB (CD137) and 5T4, a tumor antigen expressed in various types of cancers. Its preclinical candidates include APVO603, a dual agonist bispecific antibody to target 4-1BB and OX40; APVO711, a dual mechanism bispecific ADAPTIR candidate designed to provide synergistic stimulation of CD40 on antigen presenting cells; and APVO442, a bispecific candidate based on the ADAPTIR-FLEX platform technology to enhance biodistribution of drugs to PSMA positive tumors for treatment of prostate cancer. The company has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
Technical Analysis of APVO 2024-05-10
Overview:
In analyzing the technical indicators for APVO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the next few days.
Trend Anal...
Recent News & Updates
- 2024-05-13 20:05
- 2024-05-08 00:54
- 2024-05-07 20:05
- 2024-05-01 19:37
- 2024-04-16 00:47
- 2024-04-15 04:05
- 2024-04-10 20:15
Why Is Aptevo Therapeutics (APVO) Stock Down 56% Today?(Investorplace)
- 2024-04-10 20:00
- 2024-04-09 21:00
Aptevo Therapeutics Provides Pipeline Update(Accesswire)
- 2024-03-17 18:00
- 2024-03-06 19:55
- 2024-03-05 00:51
- 2024-03-04 19:05
- 2024-03-03 20:00
- 2023-11-13 19:05
- 2023-10-31 19:45
Aptevo to Present at Bio-Europe Conference(Accesswire)
- 2023-08-09 20:05
- 2023-08-05 19:14
10 Oversold Value Stocks To Buy(Yahoo Finance)
- 2023-08-04 06:40
- 2023-08-01 10:15
- 2023-07-30 02:17
- 2023-07-17 20:05
- 2023-05-10 20:05
- 2023-03-31 20:51
- 2023-03-29 19:45
- 2023-03-29 19:30
- 2023-03-28 22:13
12 Cheap Healthcare Stocks to Buy in 2023(Yahoo Finance)
- 2023-03-03 05:57
The Top 7 Growth Stocks in Biotech(Yahoo Finance)
- 2023-02-12 19:05
- 2023-01-08 19:05
Page 1 of 4
previousnext